News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
AstraZeneca Pharmaceuticals LP
NEWS
JOBS
IN THE PRESS
NEWS
Business
Massachusetts’ Flexion Terminates R&D Deal With AstraZeneca PLC
September 15, 2017
·
2 min read
Deals
AstraZeneca PLC Offloads Remaining Anesthetics Portfolio in $766 Million Deal
September 14, 2017
·
3 min read
AstraZeneca PLC: Is It Investable After Imfinzi Failure?
September 8, 2017
·
1 min read
Drug Development
Investors Wait with Bated Breath for AstraZeneca PLC’s Cancer Trial Data Next Week
September 1, 2017
·
3 min read
Deals
Daiichi Sankyo Denies AstraZeneca PLC Courtship
August 31, 2017
·
2 min read
Deals
Rumor Alert: Struggling AstraZeneca PLC Made a Pass at This $16 Billion Japanese Drugmaker Last Year
August 31, 2017
·
3 min read
Business
AstraZeneca PLC To Dump Serious Cash To Expand Largest UK Site Ahead Of Brexit
August 29, 2017
·
1 min read
Business
AstraZeneca PLC Jumps Deeper Into mRNA Drugs With Ethris Deal
August 21, 2017
·
3 min read
FDA
Heads Up Tesaro: AstraZeneca PLC, Merck & Co.'s Ovarian Cancer Drug Just Got Expanded Use From the FDA
August 18, 2017
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Cellectis Announces 2026 Strategy and Catalysts
January 9, 2026
·
7 min read
Press Releases
Rick R. Suarez appointed US President and Head of US BioPharmaceuticals Business Unit
January 8, 2026
·
2 min read
Press Releases
BostonGene and AstraZeneca Announce Strategic Collaboration to Advance Foundation Model-Driven Oncology Development
January 6, 2026
·
2 min read
Press Releases
HUTCHMED Announces NDA Acceptance in China with Priority Review Status for Savolitinib for the treatment of Gastric Cancer Patients with MET Amplification
December 30, 2025
·
5 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation in the US as post-neoadjuvant therapy for patients with HER2-positive early breast cancer
December 23, 2025
·
19 min read
Press Releases
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer
December 23, 2025
·
20 min read
Press Releases
ENHERTU® Granted Breakthrough Therapy Designation in the U.S. as Post-Neoadjuvant Therapy for Patients with HER2 Positive Early Breast Cancer
December 23, 2025
·
19 min read
Press Releases
Niowave Expands Global Supply Agreement with AstraZeneca to Deliver Actinium-225 for Next-Generation Cancer Therapies
December 19, 2025
·
2 min read
Press Releases
DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy
December 18, 2025
·
9 min read
Press Releases
ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive metastatic breast cancer
December 16, 2025
·
19 min read
